These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1660 related articles for article (PubMed ID: 25731615)

  • 41. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Scavenger Receptor-A deficiency impairs immune response of microglia and astrocytes potentiating Alzheimer's disease pathophysiology.
    Cornejo F; Vruwink M; Metz C; Muñoz P; Salgado N; Poblete J; Andrés ME; Eugenín J; von Bernhardi R
    Brain Behav Immun; 2018 Mar; 69():336-350. PubMed ID: 29246456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of activated microglia on astrogliosis parameters in astrocyte cultures.
    Röhl C; Lucius R; Sievers J
    Brain Res; 2007 Jan; 1129(1):43-52. PubMed ID: 17169340
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease.
    Dandrea MR; Reiser PA; Gumula NA; Hertzog BM; Andrade-Gordon P
    Biotech Histochem; 2001 Mar; 76(2):97-106. PubMed ID: 11440311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Short-Term Effects of Microglia-Specific Mitochondrial Dysfunction on Amyloidosis in Transgenic Models of Alzheimer's Disease.
    Steffen J; Stenzel J; Ibrahim S; Pahnke J
    J Alzheimers Dis; 2018; 65(2):465-474. PubMed ID: 30040730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease.
    Duffy AM; Hölscher C
    Neuroscience; 2013 Jan; 228():294-300. PubMed ID: 23103794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibiting TLR2 activation attenuates amyloid accumulation and glial activation in a mouse model of Alzheimer's disease.
    McDonald CL; Hennessy E; Rubio-Araiz A; Keogh B; McCormack W; McGuirk P; Reilly M; Lynch MA
    Brain Behav Immun; 2016 Nov; 58():191-200. PubMed ID: 27422717
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease.
    Jin JJ; Kim HD; Maxwell JA; Li L; Fukuchi K
    J Neuroinflammation; 2008 May; 5():23. PubMed ID: 18510752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ablation of reactive astrocytes exacerbates disease pathology in a model of Alzheimer's disease.
    Katsouri L; Birch AM; Renziehausen AWJ; Zach C; Aman Y; Steeds H; Bonsu A; Palmer EOC; Mirzaei N; Ries M; Sastre M
    Glia; 2020 May; 68(5):1017-1030. PubMed ID: 31799735
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disrupted glial fibrillary acidic protein network in astrocytes from vimentin knockout mice.
    Galou M; Colucci-Guyon E; Ensergueix D; Ridet JL; Gimenez y Ribotta M; Privat A; Babinet C; Dupouey P
    J Cell Biol; 1996 May; 133(4):853-63. PubMed ID: 8666670
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence for altered Numb isoform levels in Alzheimer's disease patients and a triple transgenic mouse model.
    Chigurupati S; Madan M; Okun E; Wei Z; Pattisapu JV; Mughal MR; Mattson MP; Chan SL
    J Alzheimers Dis; 2011; 24(2):349-61. PubMed ID: 21258150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of genetic removal of GFAP and/or vimentin on glutamine levels and transport of glucose and ascorbate in astrocytes.
    Pekny M; Eliasson C; Siushansian R; Ding M; Dixon SJ; Pekna M; Wilson JX; Hamberger A
    Neurochem Res; 1999 Nov; 24(11):1357-62. PubMed ID: 10555775
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aquaporin-4 reduces neuropathology in a mouse model of Alzheimer's disease by remodeling peri-plaque astrocyte structure.
    Smith AJ; Duan T; Verkman AS
    Acta Neuropathol Commun; 2019 May; 7(1):74. PubMed ID: 31068220
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Specific gene expression in mouse cortical astrocytes is mediated by a 1740bp-GFAP promoter-driven combined adeno-associated virus 2/5/7/8/9.
    Meng X; Yang F; Ouyang T; Liu B; Wu C; Jiang W
    Neurosci Lett; 2015 Apr; 593():45-50. PubMed ID: 25778419
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of phagocytic activity in astrocytes by reduced expression of the inflammasome component ASC and its implication in a mouse model of Alzheimer disease.
    Couturier J; Stancu IC; Schakman O; Pierrot N; Huaux F; Kienlen-Campard P; Dewachter I; Octave JN
    J Neuroinflammation; 2016 Jan; 13():20. PubMed ID: 26818951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-β plaque and glial pathology in a mouse model of Alzheimer's disease.
    Long-Smith CM; Manning S; McClean PL; Coakley MF; O'Halloran DJ; Holscher C; O'Neill C
    Neuromolecular Med; 2013 Mar; 15(1):102-14. PubMed ID: 23011726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice.
    Seabrook TJ; Jiang L; Maier M; Lemere CA
    Glia; 2006 May; 53(7):776-82. PubMed ID: 16534778
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Astrocytes negatively regulate neurogenesis through the Jagged1-mediated Notch pathway.
    Wilhelmsson U; Faiz M; de Pablo Y; Sjöqvist M; Andersson D; Widestrand A; Potokar M; Stenovec M; Smith PL; Shinjyo N; Pekny T; Zorec R; Ståhlberg A; Pekna M; Sahlgren C; Pekny M
    Stem Cells; 2012 Oct; 30(10):2320-9. PubMed ID: 22887872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inactivation of the glial fibrillary acidic protein gene, but not that of vimentin, improves neuronal survival and neurite growth by modifying adhesion molecule expression.
    Menet V; Giménez y Ribotta M; Chauvet N; Drian MJ; Lannoy J; Colucci-Guyon E; Privat A
    J Neurosci; 2001 Aug; 21(16):6147-58. PubMed ID: 11487638
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Indirubin-3'-monoxime rescues spatial memory deficits and attenuates beta-amyloid-associated neuropathology in a mouse model of Alzheimer's disease.
    Ding Y; Qiao A; Fan GH
    Neurobiol Dis; 2010 Aug; 39(2):156-68. PubMed ID: 20381617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 83.